Lack of association between antimyelin antibodies and progression to multiple sclerosis - Reply

被引:0
|
作者
Kappos, Ludwig [1 ]
Kuhle, Jens
Sandbrink, Rupert
机构
[1] Univ Basel Hosp, CH-4031 Basel, Switzerland
[2] Bayer Schering Pharma, D-13342 Berlin, Germany
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2007年 / 356卷 / 18期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1889 / 1889
页数:1
相关论文
共 50 条
  • [1] Lack of association between antimyelin antibodies and progression to multiple sclerosis
    Berger, Thomas
    Reindl, Markus
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18): : 1888 - 1889
  • [2] Lack of association between antimyelin antibodies and progression to multiple sclerosis
    Kuhle, Jens
    Pohl, Christoph
    Mehling, Matthias
    Edan, Gilles
    Freedman, Mark S.
    Hartung, Hans-Peter
    Polman, Chris H.
    Miller, David H.
    Montalban, Xavier
    Barkhof, Frederik
    Bauer, Lars
    Dahms, Susanne
    Lindberg, Raija
    Kappos, Ludwig
    Sandbrink, Rupert
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (04): : 371 - 378
  • [3] Antimyelin antibodies with no progression to multiple sclerosis
    Pelayo, Raul
    Tintore, Mar
    Montalban, Xavier
    Rovira, Alex
    Espejo, Carmen
    Reindl, Markus
    Berger, Thomas
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (04): : 426 - 428
  • [4] Antimyelin antibodies are not prognostic for progression to multiple sclerosis
    Nature Clinical Practice Neurology, 2007, 3 (5): : 242 - 242
  • [5] Antimyelin antibodies in multiple sclerosis
    Mantegazza, R
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (23): : 2270 - 2270
  • [6] The association between menopause and the multiple sclerosis progression
    de Caneda, M. A.
    Silva, C. B.
    de Vecino, M. C.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 113 - 113
  • [7] Prognostic relevance of antimyelin antibodies for the progression to multiple sclerosis after a first demyelinating event: Results of the BENEFIT trial
    Kuhle, J.
    Mehling, M.
    Hartung, H. -P.
    Freedman, M. S.
    Polman, C. H.
    Edan, G.
    Miller, D. H.
    Montalban, X.
    Bauer, L.
    Dahms, S.
    Pohl, C.
    Sandbrink, R.
    Lindberg, R.
    Kappos, L.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 55 - 55
  • [8] LACK OF ASSOCIATION BETWEEN MACROCYTOSIS AND MULTIPLE-SCLEROSIS
    GRASSO, MG
    COLLELUORI, A
    MILLEFIORINI, E
    POZZILLI, C
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1992, 55 (11): : 1096 - 1096
  • [9] AZATHIAPRINE THERAPY EFFECTS ON ANTIMYELIN AND OTHER ANTIBODIES IN MULTIPLE-SCLEROSIS
    WILKERSON, LD
    LISAK, RP
    ZWEIMAN, B
    FEDERATION PROCEEDINGS, 1975, 34 (03) : 968 - 968
  • [10] LUPOID SCLEROSIS WITH ANTIPHOSPHOLIPID AND ANTIMYELIN ANTIBODIES
    MARULLO, S
    CLAUVEL, JP
    INTRATOR, L
    DANON, F
    BROUET, JC
    OKSENHENDLER, E
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (04) : 747 - 749